Cellply is a biotechnology and medical-device company committed to the development of tools for personalized cancer therapy based on diagnostic platforms that define cell response to drug treatments. The IVD platform developed at Cellply is based on proprietary micro-technologies enabling ex-vivo measurement of the response of cells in the sample to diverse drug treatments, with single-cell accuracy. The technology supports the automation of biological protocols and allows the integration of sample preparation and functional analysis procedures. Cellply is an innovative start-up company based in Bologna, Italy and funded by private and institutional investors.
Other information on our webpage: cellply.com